Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-31 @ 4:07 PM
Study NCT ID:
NCT00942994
Status:
COMPLETED
Last Update Posted:
2011-06-08
First Post:
2009-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06
Start Date Type:
None
Primary Completion Date:
2010-03
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2009-07-19
First Submit QC Date:
None
Study First Post Date:
2009-07-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-03-29
Results First Submit QC Date:
None
Results First Post Date:
2011-04-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-05-16
Last Update Post Date:
2011-06-08
Last Update Post Date Type:
ESTIMATED